<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211103052956N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-08-10</date_registration>
      <primary_sponsor>Ragheb Isfahani higher education institute</primary_sponsor>
      <public_title>Effects of Electrical Stimulation on Lumbar Lordosis and Pelvic Tilt in Women</public_title>
      <acronym>NMES-Lordosis Trial</acronym>
      <scientific_title>Additive Effects of Active Versus Sham Neuromuscular Electrical Stimulation Added to Core-Pelvic Stability Training in Women with Lumbar Hyperlordosis and Anterior Pelvic Tilt: A Randomized Controlled Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/92363</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Factorial, Purpose: Other, Randomization description: Randomization was performed using permuted blocks of six with a 1:1:1 allocation ratio. The random sequence was generated by an independent biostatistician, and group allocation was concealed using sequentially numbered opaque sealed envelopes (SNOSE), Blinding description: Outcome assessors and statisticians were blinded to group allocation. Participants and trainers could not be blinded due to the exercise-based nature of the intervention, but participants were instructed not to disclose their group assignment during testing sessions.</study_design>
      <phase>N/A</phase>
      <hc_freetext>hyperlordosis.</hc_freetext>
      <i_freetext>Intervention group: exercise.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
De-identified individual participant data (IPD): Includes demographic data (age, height, weight, BMI), primary outcome data (lumbar lordosis angle at two time points), secondary outcome data (anterior pelvic tilt angle and plank endurance time at two time points), and group allocation data. All data will be shared after removing identifiable information (names, surnames, contact numbers, and addresses).

When:
Access Start: 6 months after publication of the study results in a peer-reviewed scientific journal.

Access End: Up to 5 years after publication of results (in accordance with ICMJE standards).

Estimated Publication Date: Within 12 months after study completion (study completion: 8 weeks after last participant enrollment).

To whom:
Researchers affiliated with academic and scientific institutions who submit a written request and obtain approval from their institutional ethics committee. Also, researchers intending to conduct secondary analyses or meta-analyses for scientific and non-commercial purposes.

Additional conditions: Priority will be given to researchers who have an approved research proposal from their institutional ethics committee and sign a non-disclosure agreement committing to use the data solely for scientific purposes.

Conditions:
Data and documents may be used exclusively for scientific and research purposes. Permitted uses include:

Secondary analyses for research purposes

Meta-analyses and systematic reviews

Validation of the original study results

Education and research methodology training

Conditions of use:

Proper citation of the original article is mandatory

Commercial or for-profit use is prohibited

Any new publication of results must be coordinated with the responsible authors

Data must not be transferred to third parties

Where to obtain:
Name: Dr. Saeid Rostami (Corresponding Author and General Public Contact Person)

Email: srostami.20@gmail.com

Phone: 00989131088601

Postal Address: Department of Sport Sciences, Faculty of Human Sciences, Ragheb Isfahani Higher Education Institute, Isfahan, Iran. Postal Code: 81551-39998

Initial Contact Method: Submit a written request via email, including the study title, IRCT registration code, and proposed research plan for data analysis.

How to obtain:
Request Process Steps:

Submit a written request via email to the corresponding author (including: study title, IRCT code, requester's full details, institutional affiliation, and purpose of data use)

Initial review by the research team (maximum 2 weeks)

If approved: Send the non-disclosure agreement and data use agreement form for signature

Receive signed form and final approval from the requester's institutional ethics committee

Send data/documents via email or secure download link (maximum 4 weeks after final approval)

Total Process Time: Approximately 4 to 6 weeks from receipt of a complete request

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Saeid Rostami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bassij</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8136478549</zip>
        <telephone>0098313687040</telephone>
        <email>srostami.20@gmail.com</email>
        <affiliation>Ragheb Isfahani higher education institute</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Saeid Rostami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bassij</address>
        <city>isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>84164835498</zip>
        <telephone>0098313687040</telephone>
        <email>srostami.20@gmail.com</email>
        <affiliation>Ragheb Isfahani higher education institute</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Women aged 25–40 yearsLumbar lordosis &gt;45° (measured by flexible ruler)Anterior pelvic tilt &gt;12° (measured by digital inclinometer)</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>40 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>History of spinal surgery or fracture, Acute or chronic low back pain requiring treatment within the past year, Neurological or vestibular disorders affecting balance, Pregnancy or delivery within the previous 12 months, Musculoskeletal deformities (congenital or acquired), Participation in structured core stability training within the previous 6 months, Contraindications to NMES (e.g., pacemaker, epilepsy, skin conditions at electrode sites), Inability to attend scheduled sessions</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M40.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Postural lordosis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: exercise</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Variable name: Lumbar Lordosis Angle,Unit of measurement: Degrees (°). Timepoint: The mean of three consecutive measurements will recorded. Timing of measurement: Before the start of the intervention (baseline) and immediately after the 8-week intervention period (post-intervention). Method of measurement: Measurement method: Measured using a flexible ruler (non-elastic tape) will place along the spinous processes from T12 to S2 in a relaxed standing position. The lordotic angle will calculate using the formula: angle (degrees) = 4 × (arc height / chord length) × 57.3.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ragheb Isfahani higher education institute</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-02-08</approval_date>
        <contact_name>Ethics committee of reserches (Islamic Azad university, Isfahan branch)</contact_name>
        <contact_address>Arghavanie street isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
